A PDE model for imatinib-treated chronic myelogenous leukemia

DOI10.1007/s11538-008-9336-zzbMath1149.92018OpenAlexW2096698447WikidataQ46457933 ScholiaQ46457933MaRDI QIDQ954304

Doron Levy, Peter S. Kim, Peter P. Lee

Publication date: 10 November 2008

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/s11538-008-9336-z

zbMATH Keywords

difference equationspartial differential equationsagent-based modelschronic myelogenous leukemia

Mathematics Subject Classification ID

PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50) Discrete version of topics in analysis (39A12)

Related Items (11)

Long-term treatment effects in chronic myeloid leukemia ⋮ Stability analysis of a simplified yet complete model for chronic myelogenous leukemia ⋮ Control of a consumer‐resource agent‐based model using partial differential equation approximation ⋮ Global dynamics of healthy and cancer cells competing in the hematopoietic system ⋮ On the global dynamics of a chronic myelogenous leukemia model ⋮ Controlled stochastic partial differential equations for rabbits on a grassland ⋮ Solutions of differential-difference equations arising from mathematical models of granulocytopoiesis ⋮ An ``age-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia ⋮ Mathematical analysis and global dynamics for a time-delayed Chronic Myeloid Leukemia model with treatment ⋮ Mathematical models of leukaemia and its treatment: a review ⋮ Optimal harvesting for a predator-prey agent-based model using difference equations

Cites Work

• Unnamed Item
• Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models

This page was built for publication: A PDE model for imatinib-treated chronic myelogenous leukemia